isoniazid has been researched along with pbtz169 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Chai, Y; Huang, G; Liu, M; Lu, Y; Lv, K; Wang, A; Wang, B; Wei, Z; You, X | 1 |
| Huang, M; Liu, M; Liu, Q; Lu, Y; Lv, K; Tao, Z; Wang, A; Wang, B; Wu, S; Yang, L | 1 |
| Guo, H; Huang, G; Liu, M; Lu, Y; Lv, K; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Batt, SM; Besra, GS; Huang, H; Li, G; Li, P; Lin, Z; Lu, Y; Ma, C; Wang, B; Zhang, D; Zhang, T; Zhang, X | 1 |
| Fu, L; Gu, J; Guo, H; Liu, M; Lu, Y; Lv, K; Ma, C; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Fu, L; Geng, Y; Gu, J; Liu, M; Lu, Y; Lv, K; Ma, C; Tao, Z; Wang, A; Wang, B; Wang, H | 1 |
| Han, B; Li, L; Liu, H; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wang, A; Wang, B | 1 |
| Fu, L; Han, B; Liu, H; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wang, A; Wang, B; Wang, H; Zhang, K | 1 |
| Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K | 1 |
| Franzblau, SG; Fu, L; Gu, J; Han, B; Liu, M; Lu, Y; Lv, K; Ma, C; Ma, X; Tao, Z; Wan, B; Wang, A; Xu, S | 1 |
| Chai, Y; Fu, L; Jia, X; Liu, M; Liu, X; Lu, Y; Lv, K; Ma, C; Wang, A; Wang, B | 1 |
| Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
| Chai, Y; Liu, M; Lu, Y; Lv, K; Ma, C; Qin, X; Wang, A; Wang, B; Wang, D; Xia, G; Xu, S | 1 |
| Chai, Y; Jiang, B; Liu, M; Lu, Y; Lv, K; Qin, X; Wang, A; Wang, B; Wang, D; Wu, W; Xia, G; Xu, S | 1 |
| Castagnolo, D; Denny, WA; Dos Santos, JL; Fernandes, GFS; Thompson, AM | 1 |
3 review(s) available for isoniazid and pbtz169
| Article | Year |
|---|---|
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Tuberculosis Drug Discovery: Challenges and New Horizons.
Topics: Antitubercular Agents; COVID-19 Drug Treatment; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis | 2022 |
14 other study(ies) available for isoniazid and pbtz169
| Article | Year |
|---|---|
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents.
Topics: | 2017 |
Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Humans; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Piperidines; Thiazines; Tuberculosis | 2018 |
Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
Topics: Anti-Bacterial Agents; Benzamides; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2018 |
Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Dose-Response Relationship, Drug; Female; HEK293 Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazines; Vero Cells | 2018 |
Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Topics: Antitubercular Agents; Area Under Curve; Drug Resistance, Multiple; Hydrophobic and Hydrophilic Interactions; Imidazoles; Mycobacterium tuberculosis; Piperazine; Piperazines; Pyridines; Structure-Activity Relationship; Thiazines | 2019 |
Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Design; Female; Imidazoles; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship; Vero Cells | 2019 |
Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Female; Imidazoles; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyridines; Structure-Activity Relationship | 2019 |
hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents.
Topics: Antitubercular Agents; Benzothiazoles; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2019 |
Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Topics: Animals; Antitubercular Agents; Drug Design; Female; Humans; Mice, Inbred ICR; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oximes; Piperazines; Thiazines; Tuberculosis | 2019 |
Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
Topics: Alkanes; Animals; Antitubercular Agents; Drug Design; Drug Resistance; Mice; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazines; Tuberculosis, Multidrug-Resistant | 2020 |
Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Thiazines | 2021 |
Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Oxadiazoles; Structure-Activity Relationship | 2022 |